These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

546 related articles for article (PubMed ID: 9311924)

  • 41. How to Deliver a More Persuasive Message Regarding Addiction as a Medical Disorder.
    Humphreys K
    J Addict Med; 2017; 11(3):174-175. PubMed ID: 28557959
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Addressing the critical health problem of adolescent substance use through health care, research, and public policy.
    Feinstein EC; Richter L; Foster SE
    J Adolesc Health; 2012 May; 50(5):431-6. PubMed ID: 22525104
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Drugs and alcohol: treating and preventing abuse, addiction and their medical consequences.
    Volkow ND; Li TK
    Pharmacol Ther; 2005 Oct; 108(1):3-17. PubMed ID: 16098597
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Responsibility and choice in addiction.
    Committee on Addictions of the Group for the Advancement of Psychiatry
    Psychiatr Serv; 2002 Jun; 53(6):707-13. PubMed ID: 12045307
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MicroRNAs in drug addiction: Current status and future perspectives.
    Zhao Y; Qin F; Han S; Li S; Zhao Y; Wang H; Tian J; Cen X
    Pharmacol Ther; 2022 Aug; 236():108215. PubMed ID: 35609719
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Successful prevention of addiction in adolescents also requires society's commitment].
    Söder M
    Dtsch Med Wochenschr; 2009 Nov; 134(47):2415. PubMed ID: 19911338
    [No Abstract]   [Full Text] [Related]  

  • 47. Compulsivity in obsessive-compulsive disorder and addictions.
    Figee M; Pattij T; Willuhn I; Luigjes J; van den Brink W; Goudriaan A; Potenza MN; Robbins TW; Denys D
    Eur Neuropsychopharmacol; 2016 May; 26(5):856-68. PubMed ID: 26774279
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Addiction in Singapore: changing patterns and evolving challenges.
    Peh AL; Lim YC; Winslow RM
    Singapore Med J; 2012 Jul; 53(7):435-7; quiz 438. PubMed ID: 22815010
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Assessing the place of neurobiological explanations in accounts of a family member's addiction.
    Meurk C; Fraser D; Weier M; Lucke J; Carter A; Hall W
    Drug Alcohol Rev; 2016 Jul; 35(4):461-9. PubMed ID: 26332006
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of Dopamine Signaling in Drug Addiction.
    Chen W; Nong Z; Li Y; Huang J; Chen C; Huang L
    Curr Top Med Chem; 2017; 17(21):2440-2455. PubMed ID: 28474551
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Etiological theories of addiction: A comprehensive update on neurobiological, genetic and behavioural vulnerability.
    Ouzir M; Errami M
    Pharmacol Biochem Behav; 2016 Sep; 148():59-68. PubMed ID: 27306332
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Similarities and Differences in Neuroimaging.
    Sun YK; Sun Y; Lin X; Lu L; Shi J
    Adv Exp Med Biol; 2017; 1010():73-89. PubMed ID: 29098669
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Current clinical aspects of drug addiction].
    Laqueille X; Uribé M; Olié JP
    Rev Prat; 1995 Jun; 45(11):1359-63. PubMed ID: 7659983
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Drug addiction in pregnancy: disease not moral failure.
    Maguire D
    Neonatal Netw; 2014; 33(1):11-8. PubMed ID: 24413031
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Stress, habits, and drug addiction: a psychoneuroendocrinological perspective.
    Schwabe L; Dickinson A; Wolf OT
    Exp Clin Psychopharmacol; 2011 Feb; 19(1):53-63. PubMed ID: 21341923
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neuro-chemical activation of brain reward meso-limbic circuitry is associated with relapse prevention and drug hunger: a hypothesis.
    Blum K; Gold MS
    Med Hypotheses; 2011 Apr; 76(4):576-84. PubMed ID: 21306831
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Scepticism and hope in a complex predicament: People with addictions deliberate about neuroscience.
    Meurk C; Morphett K; Carter A; Weier M; Lucke J; Hall W
    Int J Drug Policy; 2016 Jun; 32():34-43. PubMed ID: 27142450
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The role of metabotropic glutamate receptors in drug reward, motivation and dependence.
    Markou A
    Drug News Perspect; 2007 Mar; 20(2):103-8. PubMed ID: 17440633
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sex differences in addictive disorders.
    Fattore L; Melis M; Fadda P; Fratta W
    Front Neuroendocrinol; 2014 Aug; 35(3):272-84. PubMed ID: 24769267
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Social judgments of behavioral versus substance-related addictions: a population-based study.
    Konkolÿ Thege B; Colman I; el-Guebaly N; Hodgins DC; Patten SB; Schopflocher D; Wolfe J; Wild TC
    Addict Behav; 2015 Mar; 42():24-31. PubMed ID: 25462650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.